Meet the media team
Find a media contact in your region
Total 21 Results for:
Showing 12 out of 21 results
14 February 2025
Herbert Smith Freehills advises Chemist Warehouse on its A$34 billion merger with Sigma Healthcare
The re-listing of Sigma Healthcare (ASX:SIG) on the Australian Securities Exchange yesterday marks the full implementation of the merger between Chemist …
17 December 2024
Herbert Smith Freehills launches new Legal Professional Privilege Online Tool in Australia
Herbert Smith Freehills’ market leading disputes and regulatory experts have today launched the Legal Professional Privilege (LPP) in Australia Online …
13 November 2024
Herbert Smith Freehills navigates successful ACCC clearance for Chemist Warehouse in Sigma merger
Herbert Smith Freehills is pleased to have assisted Chemist Warehouse in obtaining clearance from the Australian Competition and Consumer Commission …
25 September 2024
Herbert Smith Freehills advises Healius Limited on the sale of Lumus Imaging to Affinity Equity Partners
Herbert Smith Freehills (HSF) is delighted to have assisted Healius Limited (Healius) on the sale of Lumus Imaging to funds managed by Affinity Equity …
11 October 2021
Herbert Smith Freehills advises IFM on sale of Genie Solutions to Pacific Equity Partners’ owned Citadel
Herbert Smith Freehills has advised IFM Investors’ private equity arm on the sale of its majority owned medical practice management software business, …
9 April 2021
Herbert Smith Freehills advises Rosemary Health on Series Seed-2 capital raise
Herbert Smith Freehills’ Venture Capital team has advised Rosemary Health on its Series Seed-2 capital raise.Rosemary Health is a telehealth platform …
22 March 2021
2021 M&A predictions hold up in first quarter, but challenges remain
Predictions for an active year for Asia Pacific M&A in a new report from global law firm Herbert Smith Freehills are holding up in the first quarter, …
24 February 2021
Australian IPOs defy early expectations to achieve record end to 2020
The outlook for Australian IPO activity in 2021 is promising following a spate of listings on the ASX in the second half of 2020, according to a new …
27 November 2020
Herbert Smith Freehills advises on Gland Pharma’s US$872 million India IPO / 史密夫斐尔律师事务所为Gland Pharma 8.72亿美元印度IPO提供法律服务
Leading global law firm Herbert Smith Freehills has advised the book running lead managers on the global offering and listing of Gland Pharma Limited on …
29 October 2020
Herbert Smith Freehills advises Rosemary Health on Series Seed capital raise
Herbert Smith Freehills’ venture capital team has advised Rosemary Health on its Series Seed capital raise.Rosemary Health is telehealth platform that …
8 July 2020
Herbert Smith Freehills’ finance team advises Crescent Capital Partners on acquisition of PRP Group
Herbert Smith Freehills has advised Crescent Capital Partners on the debt financing aspects of its acquisition of PRP Group. Crescent has been the most …
17 June 2020
Herbert Smith Freehills advises Healius on the sale of its medical and dental centres business
Herbert Smith Freehills’ M&A team has advised Healius Limited on the sale of its medical and dental centres business, with an enterprise value of …
Showing 12 out of 21 results
View moreSearchlight AI
Our new tracking tool keeps you current with developments in artificial intelligence in all major markets